Opko Health, Inc. (NASDAQ:OPK) Analyst Estimates And Rating

Opko Health, Inc. (NASDAQ:OPK) stock is presently standing at about $7.92 and lots of equity research firms seem to have a target price set on the stock. The median one-year price target of 5 analysts covering the company is $14.00, which suggests the stock could still rise over 43 percent. The highest analyst price target is $19.50, which implies a rally of -46 percent. And a quick view of analyst notes show that 2 are rating the stock a buy while 2 rate OPK a strong buy. There are 1 equity research firms advocating a Hold and 0 consider it Sell.

Standpoint Research analysts provided their view on Opko Health, Inc. (NASDAQ:OPK) recently. The rating firm issued a Buy rating to this company in a research note released on Jun 03, 2016. JP Morgan analysts disclosed their opinion on Opko Health, Inc. (NASDAQ:OPK) recently. The rating firm gave a Overweight rating to this stock in a research note published on Oct 16, 2015. According to a research note disclosed on Jun 03, 2016, analysts at Standpoint Research have upped their rating on these shares from to Buy.

Opko Health, Inc. (NASDAQ:OPK) Transactions Roundup

Several insiders were part of recent insider activity for the stock. Its CEO & Chairman, 10% Owner FROST PHILLIP MD ET AL Purchased 1,800 company shares for 14350, in a transaction on 2017-03-10. Following the transaction, the CEO & Chairman, 10% Owner is left with a stake of 183,901,756 shares, currently valued at $1456501908. Meanwhile, CEO & Chairman, 10% Owner FROST PHILLIP MD ET AL purchased 3,600 shares worth $28220, through a transaction dated 2017-03-09. Following the completion of the transaction, the insider is left with a stake of 183,899,956 shares, amounting $1456487651.52. OPK CEO & Chairman, 10% Owner FROST PHILLIP MD ET AL also purchased 1,800 shares, at a stock price of $7.92. This transaction occurred on 2017-03-08 totals $14260. After this transaction, the insider’s stake stands at 183,896,356 shares, with a market value of $1456459140.

Executives hold 6.84 percent of the stock. Dr. Jane H. Hsiao, PhD is one of the biggest insider owners in Opko Health, Inc. (NASDAQ:OPK), according to U.S. Securities and Exchange Commission (SEC) filings. The insider owns 24,713,133 shares which have current market value of around $195728013.36.Steven D. Rubin is another major inside shareholder in the company. The insider owns 5,575,251 shares as of 1%, currently worth $44155987.92. Dr. Subbarao Uppaluri,PhD is ranked as third insider holder of the stock. This insider holds 3,822,869 shares with a market value around $30277122.48 as of recent close.

Opko Health, Inc. (NASDAQ:OPK) Earnings Outlook

In Opko Health, Inc. (NASDAQ:OPK)’s latest quarter, EPS moved to $-0.02 from $-0.03 in preceding quarter and revenues reached at $275.49M compared to $298.04M. Analysts had expected Opko Health, Inc. (NASDAQ:OPK) to post net income of about $-0.04 per share on $310.82M in revenue. Looking ahead, analysts on average predict that earnings for the current quarter would come in in the range of $-0.06 to $-0.02. That is compared with the $-0.03 in EPS it reported during the same period a year ago.